isotopiA

Isotopia – Advancing Nuclear Medicine 

Since 2007, Isotopia has been a global leader in radiopharmaceutical innovation, specializing in the development, manufacturing, and commercialization of advanced diagnostic and therapeutic solutions in nuclear medicine. 

Committed to improving patient outcomes, we provide high-quality radiopharmaceuticals with precise disease targeting, ensuring safety, efficacy, and reliable supply. 

Our Key Offerings: 

• Lutetium-177 (Lu-177): Supplied under GMP conditions with a robust Drug Master File, meeting the growing global demand. 

• Isoprotrace® (Ga-68 PSMA-11 kit): A single sterile vacuum-vial kit enabling multi-patient doses of Gallium-68 Gozetotide (PSMA-11) in just 5 minutes. 

With manufacturing sites in Europe, the USA, and Israel, Isotopia ensures supply security and timely delivery. Our core values—Innovation, Collaboration, Integrity, and Agility—drive our mission to make life-changing treatments accessible worldwide. 

As a trusted radiopharmaceutical partner, Isotopia is dedicated to advancing cancer care and delivering cutting-edge solutions to healthcare providers and patients.